tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

FOLD Stock Latest News

Starbucks downgraded, Oracle initiated: Wall Street’s top analyst calls
The FlyStarbucks downgraded, Oracle initiated: Wall Street’s top analyst calls
9d ago
V
MA
Amicus upgraded to Overweight from Equal Weight at Morgan Stanley
PremiumThe Fly
Amicus upgraded to Overweight from Equal Weight at Morgan Stanley
9d ago
FOLD
Amicus upgraded to Overweight from Equal Weight at Morgan Stanley
PremiumThe Fly
Amicus upgraded to Overweight from Equal Weight at Morgan Stanley
9d ago
FOLD
Amicus Therapeutics Advances Pediatric Fabry Disease Study with Migalastat
PremiumCompany Announcements
Amicus Therapeutics Advances Pediatric Fabry Disease Study with Migalastat
23d ago
FOLD
Amicus Therapeutics Advances Pompe Disease Research with New Observational Study
PremiumCompany Announcements
Amicus Therapeutics Advances Pompe Disease Research with New Observational Study
23d ago
FOLD
Amicus Therapeutics’ Migalastat Study: A Potential Game-Changer for Fabry Disease Treatment
PremiumCompany AnnouncementsAmicus Therapeutics’ Migalastat Study: A Potential Game-Changer for Fabry Disease Treatment
23d ago
FOLD
Amicus Therapeutics Expands Access to Migalastat for Fabry Disease Patients
Premium
Company Announcements
Amicus Therapeutics Expands Access to Migalastat for Fabry Disease Patients
23d ago
FOLD
Amicus Therapeutics Completes Key Study on Pompe Disease Treatment Interactions
Premium
Company Announcements
Amicus Therapeutics Completes Key Study on Pompe Disease Treatment Interactions
30d ago
FOLD
Amicus announces approval of Pombiliti + Opfolda in Japan
PremiumThe Fly
Amicus announces approval of Pombiliti + Opfolda in Japan
1M ago
FOLD
Amicus Stockholders Approve Directors and Equity Plan
PremiumCompany Announcements
Amicus Stockholders Approve Directors and Equity Plan
2M ago
8K
FOLD
Amicus announces publication of post-hoc analysis of data from PROPEL study
PremiumThe Fly
Amicus announces publication of post-hoc analysis of data from PROPEL study
2M ago
FOLD
Amicus price target raised to $22 from $21 at UBS
PremiumThe Fly
Amicus price target raised to $22 from $21 at UBS
3M ago
FOLD
Amicus Positioned for Growth with Strategic Licensing and Promising FSGS Treatment
PremiumRatingsAmicus Positioned for Growth with Strategic Licensing and Promising FSGS Treatment
3M ago
FOLD
Amicus Therapeutics Reports Strong Q1 2025 Growth
Premium
Company Announcements
Amicus Therapeutics Reports Strong Q1 2025 Growth
3M ago
FOLD
Amicus’s Strategic Positioning and Growth Potential Justify Buy Rating Despite Revenue Misses
Premium
Ratings
Amicus’s Strategic Positioning and Growth Potential Justify Buy Rating Despite Revenue Misses
3M ago
FOLD
Amicus Therapeutics’ Earnings Call Highlights Growth and Strategic Moves
PremiumCompany Announcements
Amicus Therapeutics’ Earnings Call Highlights Growth and Strategic Moves
3M ago
FOLD
Amicus lowers FY25 total revenue growth view 15%-22% from 17%-24%
PremiumThe Fly
Amicus lowers FY25 total revenue growth view 15%-22% from 17%-24%
3M ago
FOLD
Amicus reports Q1 non-GAAP EPS 3c, consensus 8c
PremiumThe Fly
Amicus reports Q1 non-GAAP EPS 3c, consensus 8c
3M ago
FOLD
Amicus Secures License for DMX-200 Development
PremiumCompany Announcements
Amicus Secures License for DMX-200 Development
3M ago
8K
FOLD
Amicus Therapeutics (FOLD) Q1 Earnings Cheat Sheet
PremiumPre-EarningsAmicus Therapeutics (FOLD) Q1 Earnings Cheat Sheet
3M ago
FOLD
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
ABVC
CMPX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
APRE
BCDA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >